×
Entrez Id:
5319
Gene Symbol:
PLA2G1B
PLA2G1B
0.010
GeneticVariation
group
BEFREE
Mutations in pantothenate kinase 2 (PANK2) and phospholipase A2 (PLA2G6) cause recessive, childhood-onset extrapyramidal disorders termed pantothenate kinase-associated neurodegeneration (PKAN) and infantile neuroaxonal dystrophy (INAD), respectively.
21496576
2011
×
Entrez Id:
8398
Gene Symbol:
PLA2G6
PLA2G6
0.010
GeneticVariation
group
BEFREE
Mutations in pantothenate kinase 2 (PANK2) and phospholipase A2 (PLA2G6 ) cause recessive, childhood-onset extrapyramidal disorders termed pantothenate kinase-associated neurodegeneration (PKAN) and infantile neuroaxonal dystrophy (INAD), respectively.
21496576
2011
×
Entrez Id:
7534
Gene Symbol:
YWHAZ
YWHAZ
0.010
GeneticVariation
group
BEFREE
Mutations in pantothenate kinase 2 (PANK2) and phospholipase A2 (PLA2G6) cause recessive, childhood-onset extrapyramidal disorders termed pantothenate kinase-associated neurodegeneration (PKAN) and infantile neuroaxonal dystrophy (INAD), respectively.
21496576
2011
×
Entrez Id:
10367
Gene Symbol:
MICU1
MICU1
0.300
Biomarker
group
CTD_human
Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling.
24336167
2014
×
Entrez Id:
5155
Gene Symbol:
PDGFB
PDGFB
0.300
Biomarker
group
CTD_human
Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.
25938945
2015
×
Entrez Id:
9213
Gene Symbol:
XPR1
XPR1
0.300
Biomarker
group
CTD_human
Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.
25938945
2015
×
Entrez Id:
5159
Gene Symbol:
PDGFRB
PDGFRB
0.300
Biomarker
group
CTD_human
Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.
25938945
2015
×
Entrez Id:
6575
Gene Symbol:
SLC20A2
SLC20A2
0.300
Biomarker
group
CTD_human
Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.
25938945
2015
×
Entrez Id:
5617
Gene Symbol:
PRL
PRL
0.320
Biomarker
group
BEFREE
Our findings demonstrate that there is moderate to high level of evidence suggesting that in the treatment of schizophrenia, LAI SGAs have higher efficacy and are associated with higher rates of extrapyramidal syndrome and prolactin -related symptoms.
30466208
2018
×
Entrez Id:
5617
Gene Symbol:
PRL
PRL
0.320
GeneticVariation
group
BEFREE
The most frequently reported were ADRs related to extrapyramidal syndrome (14.7%), breast disorders or blood prolactin level changes (4.7%), and cardiac arrhythmias (4.6%).
30676073
2019